Trial Profile
A Randomized, Open-Label, Single -Dose, Crossover, Phase I Clinical Trial to Evaluate the Effect of Food on the Safety, Tolerability and Pharmacokinetics of EC-18 After Oral Administration in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Mosedipimod (Primary)
- Indications Neutropenia; Sepsis
- Focus Adverse reactions
- Sponsors Enzychem Lifesciences Corporation
- 09 Mar 2016 New trial record